
The Collaborative Research Network (CRN) is a first-of-its-kind global community of multidisciplinary and multi-institutional teams working together to spark new discoveries in Parkinson’s disease (PD) research. The CRN is a program of the Aligning Science Across Parkinson’s (ASAP) initiative, managed by the Coalition for Aligning Science and implemented by the Michael J. Fox Foundation.
The ASAP CRN supports 67 research teams across 24 countries, focusing on critical areas such as functional genomics in Parkinson’s disease, neuro-immune interactions, circuitry and brain-body interactions, PD heterogeneity, and tool generation. With collaboration at its core, the CRN brings together hundreds of investigators to share expertise, findings, and tools in an effort to tackle challenges in the PD space. As a community, we promote standards for openness, real-world utility, and collective impact across scientific research.
The Aligning Science Across Parkinson’s (ASAP) initiative launched the CRN in 2020 to catalyze breakthroughs in PD research. ASAP fosters connections across the scientific community by supporting a variety of programs designed to enhance collaboration and promote sharing of scientific findings, tools, and technologies.
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
Members of the CRN work diligently to advance our understanding of Parkinson’s disease. Learn more about recent CRN discoveries and achievements.
Cloudy With a Chance of Multi-Omics: Expanding the CRN Cloud to Facilitate Parkinson’s Research
A cornerstone of the mission of Aligning Science Across Parkinson's is the CRN Cloud, launched in June 2024 as a dedicated platform designed to curate and harmonize complex biological ‘omics data. To date, the CRN Cloud has amassed over 50 datasets, and it continues to expand to support the needs of Parkinson’s researchers.
MoMa Awardees Tackle Meta-Analysis of CRN Omics Data
Guided by our open science approach, ASAP launched the Multi-Omics Meta-Analysis (MoMa) funding opportunity to support Collaborative Research Network (CRN) researchers interested in conducting meta-analysis of omics data housed within our publicly accessible database, the CRN Cloud.
Genetic Representation in Parkinson’s Research Drives Progress
GP2 is overcoming the historical limitation of Parkinson’s genetic research — a focus on European populations only — by genotyping 250,000 volunteers globally. Learn how this approach to broaden genetic representation in Parkinson’s research paves the way to precision treatment and a better understanding of the disease.